Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Squamous Cell Carcinoma of Head and Neck 10 Uterine Cervical Neoplasms 9 Lung Neoplasms 7 Carcinoma, Non-Small-Cell Lung 7 Urinary Bladder Neoplasms 5 Stomach Neoplasms 5 Small Cell Lung Carcinoma 4 Mesothelioma, Malignant 4 Medulloblastoma 4 Urethral Neoplasms 3 Oropharyngeal Neoplasms 3 Neuroblastoma 3 Head and Neck Neoplasms 3 Ganglioneuroblastoma 3 Cholangiocarcinoma 3 Vulvar Neoplasms 2 Vaginal Neoplasms 2 Ureteral Neoplasms 2 Tongue Neoplasms 2 Prostatic Neoplasms 2 Ovarian Neoplasms 2 Lymphoid Interstitial Pneumonia 2 Gallbladder Neoplasms 2 Fallopian Tube Neoplasms 2 Esophageal Neoplasms 2 Carcinoma, Transitional Cell 2 Carcinoma, Hepatocellular 2 Brenner Tumor 2 Brain Neoplasms 2 Vomiting 1

Interventions

Ifosfamide 11 Methotrexate 9 Doxorubicin 7 Magnetic Resonance Spectroscopy 6 Filgrastim 6 Cisplatin 6 Leucovorin 5 Etoposide 5 X-Rays 4 Specimen Handling 4 Sirolimus 4 Phantoms, Imaging 4 Gemcitabine 4 temsirolimus 3 sargramostim 3 dinutuximab 3 cixutumumab 3 Radiotherapy 3 Nuclear Medicine Department, Hospital 3 Granulocyte-Macrophage Colony-Stimulating Factor 3 Dexrazoxane 3 Cyclophosphamide 3 Biopsy 3 ulixertinib 2 tipifarnib 2 tazemetostat 2 selpercatinib 2 samarium Sm-153 lexidronam 2 palbociclib 2 olaparib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Osteosarcoma × Platinum × Clear all

NCT00134030 2023-06-07

EURAMOS-1

Children's Oncology Group

Phase 3 Completed

1,334 enrolled 17 charts

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡